Quarterly Result2 Nov 2026, 05:30 pm
Shree Ganesh Biotech Declares Un-audited Q2 FY27 Results
AI Summary
Shree Ganesh Biotech (India) Ltd announced its un-audited financial results for the quarter and half-year ended September 30, 2026. The Board of Directors convened on November 2, 2026, to approve these results. The company reported a net loss for the quarter and half-year. The financial statements were reviewed by the Audit Committee and underwent a limited review by the Statutory Auditors.
Key Highlights
- Board approved un-audited financial results for Q2 FY27.
- Results cover the quarter and half-year ended September 30, 2026.
- Company reported a net loss for the period.
- Financials were subject to a limited review by statutory auditors.
Price Impact
More from SHREEGANES